Cannabis Therapeutics and the Future of Neurology

Ethan B. Russo* Front. Integr. Neurosci., 18 October 2018 |
https://doi.org/10.3389/fnint.2018.00051

[Infolink: https://www.frontiersin.org/articles/10.3389/fnint.2018.00051]

This review will examine the discoveries and roles of cannabis in offering intriguing neurological therapeutics via neutral phytocannabinoids:

THC: tetrahydrocannabinol,
CBD: cannabidiol their acidic precursors,
THCA: tetrahydrocannabinolic acid
CBDA: cannabidiolic acid
Terpenoids

Putative treatment of five syndromes, currently labeled recalcitrant to therapeutic success, and wherein improved pharmacological intervention is required:

Intractable epilepsy,
Brain tumors,
Parkinson disease (PD),
Alzheimer disease (AD) and
Traumatic brain injury (TBI)/chronic traumatic encephalopathy (CTE)

Image Source:

#cannabis-collective, #canna-curate
#cannabinoids, #cannabidiol, #neurological, #phytocannabinoids, #Parkinson, #Alzheimer, #Terpenoids